Cardiovascular Pathology
Volume 19, Issue 3 , Pages 153-157, May 2010

Metastatic malignant melanoma manifesting as an intracardiac mass

  • Angela Wood

      Affiliations

    • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
  • ,
  • Svetomir N. Markovic

      Affiliations

    • Department of Oncology, Mayo Clinic, Rochester, MN, USA
    • The Melanoma Study Group, Mayo Clinic, Rochester, MN, USA
  • ,
  • Patricia J.M. Best

      Affiliations

    • Department of Cardiology, Mayo Clinic, Rochester, MN, USA
  • ,
  • Lori A. Erickson

      Affiliations

    • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
    • The Melanoma Study Group, Mayo Clinic, Rochester, MN, USA
    • Corresponding Author InformationCorresponding author. Division of Anatomic Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Tel.: +1 507 284 1199.

Received 29 October 2008; received in revised form 9 December 2008; accepted 19 December 2008. published online 12 February 2009.

Abstract 

Introduction

Antemortem diagnoses of intracardiac metastases are uncommon. Metastatic melanoma shows a propensity for cardiac involvement, but cardiac involvement by melanoma is rarely identified clinically due to a paucity of cardiac symptoms.

Methods

The surgical pathology files of Mayo Clinic were searched for cases of metastatic melanoma presenting or manifesting as an intracardiac mass. The lesions were evaluated pathologically for diagnoses. Clinical information was obtained by chart review.

Results

Seven patients, four female and three male (age 31 to 79 years), were identified. No patient had a history of metastatic melanoma. All patients presented with dyspnea and symptoms of outflow obstruction. Echocardiography or CT revealed an intracardiac mass (four atrial, three ventricular). Six cases involved the right side of the heart and one involved the left ventricle. Five of the seven patients had a history of malignant melanoma, but none had a history of metastases when they presented with cardiac symptoms. In four cases, the history of primary melanoma was remote, occurring 7, 9, 13, and 28 years prior to the discovery of their cardiac mass. One patient had no history of melanoma, and no primary melanoma was ever identified. One patient had a history of a benign melanocytic lesion biopsied 2 years before, but retrospective review showed malignant melanoma.

Conclusions

Melanoma is known to have an unpredictable and prolonged course. Neoplastic involvement of the heart should be considered in patients with cardiac symptoms when a documented malignancy exists, no matter how remote.

Keywords: Heart, Cardiac, Melanoma

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 No funding was received in support of our study.

PII: S1054-8807(08)00191-9

doi:10.1016/j.carpath.2008.12.010

Cardiovascular Pathology
Volume 19, Issue 3 , Pages 153-157, May 2010